Barbara Kosacz serves as Executive at Kronos Bio, Inc., where they oversee executive responsibilities. Since joining the company, Barbara Kosacz has executed 7 insider transactions totaling $112.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 14, 2024 involved transacting 5,828 shares valued at $0.
Barbara Kosacz currently holds 5,828 shares of Kronos Bio, Inc. (KRON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Kosacz has been a net buyer of KRON stock. They have purchased $99.8K and sold $12.6K worth of shares.
Barbara Kosacz's most recent insider trade was on Feb 14, 2024, when they sold 5,828 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.18 |
| Discretionary |
| Feb 15, 2023 | KRON | $0 | Award | 138,911 | $N/A | Discretionary |
| Jul 25, 2022 | KRON | $0 | Award | 53,600 | $N/A | Discretionary |
| Feb 15, 2022 | KRON | $0 | Award | 53,600 | $N/A | Discretionary |
| Dec 9, 2020 | KRON | $0 | Award | 69,824 | $N/A | Discretionary |
| Oct 14, 2020 | KRON | $99.8K | Purchase | 5,250 | $19.00 | Discretionary |